Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bácskay I[au]:

Search results

Items: 1 to 50 of 58

1.

Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.

Nemes D, Kovács R, Nagy F, Tóth Z, Herczegh P, Borbás A, Kelemen V, Pfliegler WP, Rebenku I, Hajdu PB, Fehér P, Ujhelyi Z, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Eur J Pharm Sci. 2019 Nov 20;143:105162. doi: 10.1016/j.ejps.2019.105162. [Epub ahead of print]

2.

Biocompatibility and zinc release testing of a zinc-containing vaginal gel.

Fenyvesi F, Váradi J, Fehér P, Bácskay I, Vecsernyés M, Sipos A, Takacs P.

Menopause. 2019 Oct 14. doi: 10.1097/GME.0000000000001435. [Epub ahead of print]

PMID:
31613827
3.

Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin.

Váradi J, Hermenean A, Gesztelyi R, Jeney V, Balogh E, Majoros L, Malanga M, Fenyvesi É, Szente L, Bácskay I, Vecsernyés M, Fehér P, Ujhelyi Z, Vasvári G, Árvai I, Rusznyák Á, Balta C, Herman H, Fenyvesi F.

Biomolecules. 2019 Sep 20;9(10). pii: E509. doi: 10.3390/biom9100509.

4.

Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming.

Vasvári G, Haimhoffer Á, Horváth L, Budai I, Trencsényi G, Béresová M, Dobó-Nagy C, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Vecsernyés M, Fenyvesi F.

AAPS PharmSciTech. 2019 Aug 19;20(7):290. doi: 10.1208/s12249-019-1500-2.

5.

Physiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol.

Jakab Á, Tóth Z, Nagy F, Nemes D, Bácskay I, Kardos G, Emri T, Pócsi I, Majoros L, Kovács R.

Appl Environ Microbiol. 2019 Oct 1;85(20). pii: e01388-19. doi: 10.1128/AEM.01388-19. Print 2019 Oct 15.

PMID:
31399405
6.

Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties.

Arany P, Róka E, Mollet L, Coleman AW, Perret F, Kim B, Kovács R, Kazsoki A, Zelkó R, Gesztelyi R, Ujhelyi Z, Fehér P, Váradi J, Fenyvesi F, Vecsernyés M, Bácskay I.

Pharmaceutics. 2019 Jun 13;11(6). pii: E277. doi: 10.3390/pharmaceutics11060277.

7.

The hepatoprotective effect of livergol microemulsion preparation (nanoparticle) against bromobenzene induced toxicity in mice.

Kalantari A, Salimi A, Kalantari H, Ebrahimi Broojeni J, Rashidi I, Raesi Vanani A, Bácskay I.

Toxicol Rep. 2019 May 9;6:444-448. doi: 10.1016/j.toxrep.2019.05.005. eCollection 2019.

8.

Silymarin: Friend or Foe of UV Exposed Keratinocytes?

Fidrus E, Ujhelyi Z, Fehér P, Hegedűs C, Janka EA, Paragh G, Vasas G, Bácskay I, Remenyik É.

Molecules. 2019 Apr 26;24(9). pii: E1652. doi: 10.3390/molecules24091652.

9.

Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD).

Hajdu I, Angyal J, Szikra D, Kertész I, Malanga M, Fenyvesi É, Szente L, Vecsernyés M, Bácskay I, Váradi J, Fehér P, Ujhelyi Z, Vasvári G, Rusznyák Á, Trencsényi G, Fenyvesi F.

Eur J Pharm Sci. 2019 Feb 1;128:202-208. doi: 10.1016/j.ejps.2018.12.001. Epub 2018 Dec 4.

PMID:
30521943
10.

Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis.

Gharbia S, Balta C, Herman H, Rosu M, Váradi J, Bácskay I, Vecsernyés M, Gyöngyösi S, Fenyvesi F, Voicu SN, Stan MS, Cristian RE, Dinischiotu A, Hermenean A.

Front Pharmacol. 2018 Aug 13;9:883. doi: 10.3389/fphar.2018.00883. eCollection 2018.

11.

Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.

Vasvári G, Csontos B, Sovány T, Regdon G Jr, Bényei A, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Nguyen TLP, Vecsernyés M, Fenyvesi F.

AAPS PharmSciTech. 2018 Oct;19(7):3165-3176. doi: 10.1208/s12249-018-1146-5. Epub 2018 Aug 22.

PMID:
30136176
12.

Physico-chemical characterization of self-emulsifying drug delivery systems.

Ujhelyi Z, Vecsernyés M, Fehér P, Kósa D, Arany P, Nemes D, Sinka D, Vasvári G, Fenyvesi F, Váradi J, Bácskay I.

Drug Discov Today Technol. 2018 Jul;27:81-86. doi: 10.1016/j.ddtec.2018.06.005. Epub 2018 Jun 27. Review.

PMID:
30103867
13.

Matrix systems for oral drug delivery: Formulations and drug release.

Vasvári G, Kalmár J, Veres P, Vecsernyés M, Bácskay I, Fehér P, Ujhelyi Z, Haimhoffer Á, Rusznyák Á, Fenyvesi F, Váradi J.

Drug Discov Today Technol. 2018 Jul;27:71-80. doi: 10.1016/j.ddtec.2018.06.009. Epub 2018 Jul 23. Review.

PMID:
30103866
14.

Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.

Nemes D, Kovács R, Nagy F, Mező M, Poczok N, Ujhelyi Z, Pető Á, Fehér P, Fenyvesi F, Váradi J, Vecsernyés M, Bácskay I.

Molecules. 2018 Jul 23;23(7). pii: E1827. doi: 10.3390/molecules23071827.

15.

Protective Effect of Pure Sour Cherry Anthocyanin Extract on Cytokine-Induced Inflammatory Caco-2 Monolayers.

Le Phuong Nguyen T, Fenyvesi F, Remenyik J, Homoki JR, Gogolák P, Bácskay I, Fehér P, Ujhelyi Z, Vasvári G, Vecsernyés M, Váradi J.

Nutrients. 2018 Jul 3;10(7). pii: E861. doi: 10.3390/nu10070861.

16.

Biocompatibility investigation of different pharmaceutical excipients used in liquid dosage forms.

Nemes D, Ujhelyi Z, Arany P, Pető A, Fehér P, Váradi J, Fenyvesi F, Vecsernyés M, Bácskay I.

Pharmazie. 2018 Jan 2;73(1):16-18. doi: 10.1691/ph.2018.7095.

PMID:
29441945
17.

Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.

Nacereddine A, Bollacke A, Róka E, Marminon C, Bouaziz Z, Fenyvesi F, Bácskay IK, Jose J, Perret F, Le Borgne M.

Pharmaceuticals (Basel). 2018 Jan 26;11(1). pii: E10. doi: 10.3390/ph11010010.

18.

Self-Nanoemulsifying Drug Delivery Systems Containing Plantago lanceolata-An Assessment of Their Antioxidant and Antiinflammatory Effects.

Kalantari A, Kósa D, Nemes D, Ujhelyi Z, Fehér P, Vecsernyés M, Váradi J, Fenyvesi F, Kuki Á, Gonda S, Vasas G, Gesztelyi R, Salimi A, Bácskay I.

Molecules. 2017 Oct 20;22(10). pii: E1773. doi: 10.3390/molecules22101773.

19.

Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers.

Váradi J, Harazin A, Fenyvesi F, Réti-Nagy K, Gogolák P, Vámosi G, Bácskay I, Fehér P, Ujhelyi Z, Vasvári G, Róka E, Haines D, Deli MA, Vecsernyés M.

PLoS One. 2017 Jan 19;12(1):e0170537. doi: 10.1371/journal.pone.0170537. eCollection 2017.

20.

Efficacy of Pre- and Post-Treatment by Topical Formulations Containing Dissolved and Suspended Silybum marianum against UVB-Induced Oxidative Stress in Guinea Pig and on HaCaT Keratinocytes.

Fehér P, Ujhelyi Z, Váradi J, Fenyvesi F, Róka E, Juhász B, Varga B, Bombicz M, Priksz D, Bácskay I, Vecsernyés M.

Molecules. 2016 Sep 22;21(10). pii: E1269. doi: 10.3390/molecules21101269.

21.

Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes.

Róka E, Ujhelyi Z, Deli M, Bocsik A, Fenyvesi É, Szente L, Fenyvesi F, Vecsernyés M, Váradi J, Fehér P, Gesztelyi R, Félix C, Perret F, Bácskay IK.

Molecules. 2015 Nov 11;20(11):20269-85. doi: 10.3390/molecules201119694.

22.

Endocytosis of fluorescent cyclodextrins by intestinal Caco-2 cells and its role in paclitaxel drug delivery.

Réti-Nagy K, Malanga M, Fenyvesi É, Szente L, Vámosi G, Váradi J, Bácskay I, Fehér P, Ujhelyi Z, Róka E, Vecsernyés M, Balogh G, Vasvári G, Fenyvesi F.

Int J Pharm. 2015 Dec 30;496(2):509-17. doi: 10.1016/j.ijpharm.2015.10.049. Epub 2015 Oct 21.

PMID:
26498369
23.

Effects of concurrent caffeine and mobile phone exposure on local target probability processing in the human brain.

Trunk A, Stefanics G, Zentai N, Bacskay I, Felinger A, Thuróczy G, Hernádi I.

Sci Rep. 2015 Sep 23;5:14434. doi: 10.1038/srep14434.

24.

Protein and alkaloid patterns of the floral nectar in some solanaceous species.

Kerchner A, Darók J, Bacskay I, Felinger A, Jakab G, Farkas Á.

Acta Biol Hung. 2015 Sep;66(3):304-15. doi: 10.1556/018.66.2015.3.6.

PMID:
26344026
25.

The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells.

Ujhelyi Z, Kalantari A, Vecsernyés M, Róka E, Fenyvesi F, Póka R, Kozma B, Bácskay I.

Molecules. 2015 Jul 21;20(7):13226-39. doi: 10.3390/molecules200713226.

26.

Hepatoprotective effects of a self-micro emulsifying drug delivery system containing Silybum marianum native seed oil against experimentally induced liver injury.

Fehér P, Ujhelyi Z, Vecsernyés M, Fenyvesi F, Damache G, Ardelean A, Costache M, Dinischiotu A, Hermenean A, Bácskay I.

Pharmazie. 2015 Apr;70(4):231-8.

PMID:
26012252
27.

para-Sulphonato-calix[n]arenes as selective activators for the passage of molecules across the Caco-2 model intestinal membrane.

Roka E, Vecsernyes M, Bacskay I, Félix C, Rhimi M, Coleman AW, Perret F.

Chem Commun (Camb). 2015 Jun 7;51(45):9374-6. doi: 10.1039/c5cc01777g.

PMID:
25958962
28.

Cyclodextrins, blood-brain barrier, and treatment of neurological diseases.

Vecsernyés M, Fenyvesi F, Bácskay I, Deli MA, Szente L, Fenyvesi É.

Arch Med Res. 2014 Nov;45(8):711-29. doi: 10.1016/j.arcmed.2014.11.020. Epub 2014 Dec 4. Review.

PMID:
25482528
29.

Polydispersity in size-exclusion chromatography: a stochastic approach.

Sepsey A, Bacskay I, Felinger A.

J Chromatogr A. 2014 Oct 24;1365:156-63. doi: 10.1016/j.chroma.2014.09.023. Epub 2014 Sep 17.

PMID:
25262029
30.

[Formulation and characetization of self-microemulsifying drug delivery systems according to their cytotoxic attributes].

Ujhelyi Z, Vecsernyés M, Bácskay I.

Acta Pharm Hung. 2014;84(2):69-76. Hungarian.

PMID:
25167702
31.

The pore size distribution of the first and the second generation of silica monolithic stationary phases.

Bacskay I, Sepsey A, Felinger A.

J Chromatogr A. 2014 Sep 12;1359:112-6. doi: 10.1016/j.chroma.2014.07.027. Epub 2014 Jul 18.

PMID:
25085822
32.

Lack of interaction between concurrent caffeine and mobile phone exposure on visual target detection: an ERP study.

Trunk A, Stefanics G, Zentai N, Bacskay I, Felinger A, Thuróczy G, Hernádi I.

Pharmacol Biochem Behav. 2014 Sep;124:412-20. doi: 10.1016/j.pbb.2014.07.011. Epub 2014 Jul 27.

PMID:
25073015
33.

Investigation of the cytotoxic effects of titanate nanotubes on Caco-2 cells.

Fenyvesi F, Kónya Z, Rázga Z, Vecsernyés M, Kása P Jr, Pintye-Hódi K, Bácskay I.

AAPS PharmSciTech. 2014 Aug;15(4):858-61. doi: 10.1208/s12249-014-0115-x. Epub 2014 Apr 4.

34.

Determination of the pore size distribution of high-performance liquid chromatography stationary phases via inverse size exclusion chromatography.

Bacskay I, Sepsey A, Felinger A.

J Chromatogr A. 2014 Apr 25;1339:110-7. doi: 10.1016/j.chroma.2014.02.085. Epub 2014 Mar 12.

PMID:
24666937
35.

Molecular theory of size exclusion chromatography for wide pore size distributions.

Sepsey A, Bacskay I, Felinger A.

J Chromatogr A. 2014 Feb 28;1331:52-60. doi: 10.1016/j.chroma.2014.01.017. Epub 2014 Jan 16.

PMID:
24485538
36.

Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis.

Fenyvesi F, Réti-Nagy K, Bacsó Z, Gutay-Tóth Z, Malanga M, Fenyvesi É, Szente L, Váradi J, Ujhelyi Z, Fehér P, Szabó G, Vecsernyés M, Bácskay I.

PLoS One. 2014 Jan 8;9(1):e84856. doi: 10.1371/journal.pone.0084856. eCollection 2014.

38.

Assessment of the hemolytic activity and cytotoxicity of different PEG-based solubilizing agents.

Ujhelyi Z, Róka E, Fenyvesi F, Fehér P, Váradi J, Réti-Nagy K, Vecsernyés M, Bácskay I.

Pharmazie. 2013 May;68(5):383-4.

PMID:
23802439
39.

Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.

Ujhelyi Z, Fenyvesi F, Váradi J, Fehér P, Kiss T, Veszelka S, Deli M, Vecsernyés M, Bácskay I.

Eur J Pharm Sci. 2012 Oct 9;47(3):564-73. doi: 10.1016/j.ejps.2012.07.005. Epub 2012 Jul 27.

PMID:
22841998
40.

Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer.

Fenyvesi F, Kiss T, Fenyvesi E, Szente L, Veszelka S, Deli MA, Váradi J, Fehér P, Ujhelyi Z, Tósaki A, Vecsernyés M, Bácskay I.

J Pharm Sci. 2011 Nov;100(11):4734-44. doi: 10.1002/jps.22666. Epub 2011 Jun 9.

PMID:
21660974
41.

Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.

Kiss T, Fenyvesi F, Bácskay I, Váradi J, Fenyvesi E, Iványi R, Szente L, Tósaki A, Vecsernyés M.

Eur J Pharm Sci. 2010 Jul 11;40(4):376-80. doi: 10.1016/j.ejps.2010.04.014. Epub 2010 Apr 29.

PMID:
20434542
42.

Comparison of the mass transfer in totally porous and superficially porous stationary phases in liquid chromatography.

Kiss I, Bacskay I, Kilár F, Felinger A.

Anal Bioanal Chem. 2010 Jun;397(3):1307-14. doi: 10.1007/s00216-010-3627-6. Epub 2010 Mar 19.

PMID:
20300736
43.

Dephosphorylation/inactivation of tyrosine hydroxylase at the median eminence of the hypothalamus is required for suckling-induced prolactin and adrenocorticotrop hormone responses.

Fehér P, Oláh M, Bodnár I, Hechtl D, Bácskay I, Juhász B, Nagy GM, Vecsernyés M.

Brain Res Bull. 2010 Apr 29;82(1-2):141-5. doi: 10.1016/j.brainresbull.2010.02.006. Epub 2010 Feb 16.

PMID:
20170714
44.

Dopamine-regulated adrenocorticotropic hormone secretion in lactating rats: functional plasticity of melanotropes.

Oláh M, Fehér P, Ihm Z, Bácskay I, Kiss T, Freeman ME, Nagy GM, Vecsernyés M.

Neuroendocrinology. 2009;90(4):391-401. doi: 10.1159/000232313. Epub 2009 Jul 30.

45.

Macroscopic and microscopic analysis of mass transfer in reversed phase liquid chromatography.

Bacskay I, Felinger A.

J Chromatogr A. 2009 Feb 20;1216(8):1253-62. doi: 10.1016/j.chroma.2008.11.054. Epub 2008 Nov 27.

PMID:
19081569
46.

P-glycoprotein inhibition by membrane cholesterol modulation.

Fenyvesi F, Fenyvesi E, Szente L, Goda K, Bacsó Z, Bácskay I, Váradi J, Kiss T, Molnár E, Janáky T, Szabó G Jr, Vecsernyés M.

Eur J Pharm Sci. 2008 Aug 7;34(4-5):236-42. doi: 10.1016/j.ejps.2008.04.005. Epub 2008 Apr 29.

PMID:
18539442
47.

Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives.

Kiss T, Fenyvesi F, Pasztor N, Feher P, Varadi J, Kocsan R, Szente L, Fenyvesi E, Szabo G, Vecsernyes M, Bacskay I.

Pharmazie. 2007 Jul;62(7):557-8.

PMID:
17718201
48.

Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.

Varadi J, Lekli I, Juhasz B, Bacskay I, Szabo G, Gesztelyi R, Szendrei L, Varga E, Bak I, Foresti R, Motterlini R, Tosaki A.

Life Sci. 2007 Apr 3;80(17):1619-26. Epub 2007 Feb 2.

PMID:
17321552
50.

Synthesis and cytotoxicity of leinamycin antibiotic analogues.

Szilagyi A, Fenyvesi F, Majercsik O, Pelyvas IF, Bacskay I, Fehér P, Varadi J, Vecsernyés M, Herczegh P.

J Med Chem. 2006 Sep 7;49(18):5626-30.

PMID:
16942037

Supplemental Content

Loading ...
Support Center